tiprankstipranks
T2 Biosystems Reinforces Patent Victory in EU Market
Company Announcements

T2 Biosystems Reinforces Patent Victory in EU Market

Pick the best stocks and maximize your portfolio:

T2 Biosystems ( (TTOO) ) just unveiled an announcement.

T2 Biosystems has announced the successful defense of a crucial patent for its innovative blood pathogen detection method in the EU, bolstering its intellectual property portfolio. Despite opposition from bioMerieux and others, the European Patent Office backed T2 Biosystems’ patent, reinforcing the company’s strong position in direct-from-whole blood pathogen detection. This win is expected to enhance T2 Biosystems’ market leadership and support the advancement of its technology and product offerings.

Find detailed analytics on TTOO stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyT2 Biosystems announces sale of four T2Dx Intruments to European distributor
TheFlyT2 Biosystems achieves milestone with 250,000th novel sepsis test shipped
TheFlyT2 Biosystems extends multi-year supplier agreement with Vizient
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App